3QFY14 net profit of RM 890.3m (-6.3% qoq; -16.1% yoy) took 9MFY14 to RM2,906.5m (- 17% yoy; -7.4% yoy if exclude the RM515m profit from sale of CIMB Aviva and RM150m net restructuring charges in previous year ) or only accounted for 66.4% and 66.3% of HLIB and consensus forecast , respectively , below expectations .
Lower-than- expected contribution from CIMB Niaga due to significant rise in provision (please refer to our report dated 30 Oct 2014 on CIMB Niaga’s 3QFY14 results release).
Results mainly impacted by CIMB Niaga given challenging environment in Indonesia as well as IB which suffered from lower volume and lower ECM deal flows. Excluding CIMB Niaga, the group’s 9MFY14 net profit grew by 6%.
For 4QFY14, consumer banking, IB, Treasury & Markets, Investments, Malaysia and Thailand are expected to be stable with strong growth from Singapore. However, corporate banking and Indonesia remained under pressure.
Indonesia asset qualit y remained as the main concern as situation still fluid. May deteriorate further in 4Q but due to much lower expos ure to coal and coal- related companies, it expect asset quality to bottom out by 4Q14 or 1Q15. Meanwhile, it does not expect the recent fuel price hike to have significant impact.
Deal pipeline in 1Q15 better and strong in 2Q15, expect 1HFY15 to be stronger. CIR expected to be slightly lower in FY14, Malaysia asset quality continued to improve and M&A with MBSB and RHB Cap will not impact dividend policy.
Unex pected jump in impaired loans, lower than expected loan growth and impact on non -interest income if there is a slowdown in capital markets .
FY14 forecast cut by 13% to reflect the jump in provision and other adjustments based on guidance while FY15-16 fine-tuned lower by 2-3%.
TRADING BUY
Positives - Proxy to economic growth and capital markets as well as growing regional universal bank platform and the new core banking system (1Platform).
Negatives – Impact on non-interest income if capital markets soften and impact on asset quality from higher Indonesia interest rate.
Target price lowered to RM 6.91 based on Gordon Growth with ROE of 12.4% and WACC of 10.1%.
Despite conc erns about merger dilution and duplication as well as uncertainties in Indonesia, we believe the selldown to 1.4x FY14 P/B has been over exaggerated. Moreover, it is now on par with RHB Cap in terms of pricing as a proxy to the merged entity. Maintain Trading BUY as values emerged amid uncertainties .
Source: Hong Leong Investment Bank Research - 19 Nov 2014
Chart | Stock Name | Last | Change | Volume |
---|
2024-11-18
CIMB2024-11-18
CIMB2024-11-18
CIMB2024-11-15
CIMB2024-11-15
CIMB2024-11-15
CIMB2024-11-15
CIMB2024-11-15
CIMB2024-11-13
CIMB2024-11-13
CIMB2024-11-13
CIMB2024-11-13
CIMB2024-11-13
CIMB2024-11-12
CIMB2024-11-12
CIMB2024-11-12
CIMB2024-11-11
CIMB2024-11-11
CIMB2024-11-11
CIMB2024-11-08
CIMB2024-11-08
CIMB